期刊文献+

DNAJC10基因在鼻咽癌中的表达及表达下调机制的研究 被引量:1

Studies on Expression and Regulation Mechanism of DNAJC10 Gene in NPC
下载PDF
导出
摘要 运用RT-PCR检测候选抑瘤基因DNAJC10在鼻咽癌组织中的表达,运用甲基化特异性PCR(MSPCR)技术、LOH和测序等技术分别检测DNAJC10基因在鼻咽癌组织中的甲基化状况、LOH和启动子突变情况.结果表明,DNAJC10基因在肿瘤组织中较对照慢性鼻咽炎组织表达明显下调(P<0.05).DNAJC10在鼻咽癌中不表现高甲基化,其LOH的缺失率为6.25%,突变率为66.7%.因此,DNAJC10基因的表达下调主要是其遗传改变(LOH和突变)所致. In order to detect the expression level and regulation mechanism of DNAJC10 gene in nasopharyngeal carcinoma(NPC), the expression state, methylation status, loss of heterozygosity(LOH) and mutation of DNAJC10 gene were examined by RT-PCR, MSPCR, LOH assay and sequencing respectively. The results indicated DNAJC10 gene had a lower expression level in NPC tissues compared with that in chronic nasopharyngitis tissues by statistical analysis ( P 〈 0. 05), but hypermethylation of DNAJCIO was showed neither in NPC nor in chronic nasopharyngitis tissues. LOH and sequencing results showed DNAJC10 was found to have LOH and mutations in 6.25% and 66.7% of NPC biopsies, respectively. In conclusion, the results suggest down-regulation of DNAJC10 gene in NPC should be attributed to LOH and promoter mutation.
出处 《生命科学研究》 CAS CSCD 2006年第4期362-366,共5页 Life Science Research
基金 国家科技部恶性肿瘤发生与发展的基础性研究973项目(G1998051201)
关键词 DNAJC10基因 表达 甲基化 LOH 突变 鼻咽癌 DNAJC10 gene expression methylation LOH mutation NPC
  • 相关文献

参考文献2

二级参考文献30

  • 1Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC, Reynolds SH. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 2004, 23:1405-1411
  • 2Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E, Nakajima T,et al. A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma,colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer 1994, 10:7-14
  • 3Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S. Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 1994,12:3695-3700
  • 4Cunningham C, Dunlop MG, Wyllie AH, Bird CC. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 1993, 8:1391-1396
  • 5Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX et al. Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 2000, 17:1267-1275
  • 6Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.Cancer Res 1998, 58:2196-2199
  • 7Homma Y, Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J 1995, 14: 286-291
  • 8Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279: 509-514
  • 9Moon SY, Zheng Y. Rho GTPase-activating proteins in cell regulation.Trends Cell Biol 2003, 13:13-22
  • 10Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002,420:629-635

共引文献15

同被引文献21

  • 1倪海峰,莫颖禧,周晓莹,张哲,黄光武.P14^(ARF)和P16^(INK4a)基因在鼻咽癌组织中异常甲基化及其临床意义[J].广西医学院学报,2008,18(3):341-343. 被引量:5
  • 2文进,李幼平.Meta分析中效应尺度指标的选择[J].中国循证医学杂志,2007,7(8):606-613. 被引量:129
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics [J] . CA Cancer J Clin, 2011 , 61 (2) : 69-90.
  • 4Welberg L. Epigenetics . keeping it in the family [J]. Nat Rev Neurosci, 2013, 14(7) : 458-459.
  • 5Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments [J]. Expert Rev Mol Med, 2007, 9 ( 12) :21-24.
  • 6Xiao X, Zhao W, Tian F, et al. Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma [J]. Tumour Bioi, 2014,35(4) :3755-3763.
  • 7Yang Z, Lan H, Chen X, et al. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma [J]. N eoplasma, 2014, 61 (2) : 170-176.
  • 8Du C, Huang T, Sun 0, et al. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma [J]. Cancer Lett, 20 II, 309 (l) : 54-61.
  • 9Liu XQ, Chen HK, Zhang XS, et al. Alterations of Blu, a candidate tumor suppressor gene on chromosome 3 p21. 3, in human nasopharyngeal carcinomaj J]. Int J Cancer, 2003, 106 ( 1) :60-65.
  • 10Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSFI A in nasopharyngeal carcinoma [J] . Cancer Res, 2001,61 (10): 3877-3881.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部